Atypical myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review
- 23 December 2022
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 375, 578011
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID-19Neurology Neuroimmunology & Neuroinflammation, 2020
- Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic diseaseNeurology Neuroimmunology & Neuroinflammation, 2020
- Lifting the mask on neurological manifestations of COVID-19Nature Reviews Neurology, 2020
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findingsBrain, 2020
- Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19Journal of Neuro-Ophthalmology, 2020
- COVID‐19: A Global Threat to the Nervous SystemAnnals of Neurology, 2020
- COVID-19-associated acute disseminated encephalomyelitis (ADEM)Journal of Neurology, 2020
- Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritisCurrent Opinion in Neurology, 2020
- Myelin oligodendrocyte glycoprotein antibodies in neurological diseaseNature Reviews Neurology, 2018
- Acute disseminated encephalomyelitisNeurology, 2007